These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

382 related articles for article (PubMed ID: 37175505)

  • 1. Enhancing Regulatory T Cells to Treat Inflammatory and Autoimmune Diseases.
    Fiyouzi T; Pelaez-Prestel HF; Reyes-Manzanas R; Lafuente EM; Reche PA
    Int J Mol Sci; 2023 Apr; 24(9):. PubMed ID: 37175505
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treg Enhancing Therapies to Treat Autoimmune Diseases.
    Eggenhuizen PJ; Ng BH; Ooi JD
    Int J Mol Sci; 2020 Sep; 21(19):. PubMed ID: 32977677
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Past, Present, and Future of Regulatory T Cell Therapy in Transplantation and Autoimmunity.
    Romano M; Fanelli G; Albany CJ; Giganti G; Lombardi G
    Front Immunol; 2019; 10():43. PubMed ID: 30804926
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Next Frontier of Regulatory T Cells: Promising Immunotherapy for Autoimmune Diseases and Organ Transplantations.
    Terry LV; Oo YH
    Front Immunol; 2020; 11():565518. PubMed ID: 33072105
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Antigen-Specific Regulatory T Cell Therapy in Autoimmune Diseases and Transplantation.
    Selck C; Dominguez-Villar M
    Front Immunol; 2021; 12():661875. PubMed ID: 34054826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Restoring self-tolerance in autoimmune diseases by enhancing regulatory T-cells.
    Kumar P; Saini S; Khan S; Surendra Lele S; Prabhakar BS
    Cell Immunol; 2019 May; 339():41-49. PubMed ID: 30482489
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Manufacturing regulatory T cells for adoptive cell therapy in immune diseases: A critical appraisal.
    Abhishek K; Nidhi M; Chandran S; Shevkoplyas SS; Mohan C
    Clin Immunol; 2023 Jun; 251():109328. PubMed ID: 37086957
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The role of regulatory T Cells in autoimmune orchitis.
    Jacobo P
    Andrologia; 2018 Dec; 50(11):e13092. PubMed ID: 30569653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treg Therapies Revisited: Tolerance Beyond Deletion.
    Pilat N; Sprent J
    Front Immunol; 2020; 11():622810. PubMed ID: 33633742
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Improving the Efficacy of Regulatory T Cell Therapy.
    Baeten P; Van Zeebroeck L; Kleinewietfeld M; Hellings N; Broux B
    Clin Rev Allergy Immunol; 2022 Apr; 62(2):363-381. PubMed ID: 34224053
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Regulating the regulators: Is introduction of an antigen-specific approach in regulatory T cells the next step to treat autoimmunity?
    Janssens I; Cools N
    Cell Immunol; 2020 Dec; 358():104236. PubMed ID: 33137651
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD4+ T-regulatory cells: toward therapy for human diseases.
    Allan SE; Broady R; Gregori S; Himmel ME; Locke N; Roncarolo MG; Bacchetta R; Levings MK
    Immunol Rev; 2008 Jun; 223():391-421. PubMed ID: 18613849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Engineered antigen-specific regulatory T cells for autoimmune skin conditions.
    Mukhatayev Z; Ostapchuk YO; Fang D; Le Poole IC
    Autoimmun Rev; 2021 Mar; 20(3):102761. PubMed ID: 33476816
    [TBL] [Abstract][Full Text] [Related]  

  • 14. mTOR signaling, Tregs and immune modulation.
    Chapman NM; Chi H
    Immunotherapy; 2014; 6(12):1295-311. PubMed ID: 25524385
    [TBL] [Abstract][Full Text] [Related]  

  • 15. CAR Treg: A new approach in the treatment of autoimmune diseases.
    Beheshti SA; Shamsasenjan K; Ahmadi M; Abbasi B
    Int Immunopharmacol; 2022 Jan; 102():108409. PubMed ID: 34863655
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Therapeutic Potential of Gene-Modified Regulatory T Cells: From Bench to Bedside.
    Chae WJ; Bothwell ALM
    Front Immunol; 2018; 9():303. PubMed ID: 29503652
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Regulatory T cells (Tregs) and their therapeutic potential against autoimmune disorders - Advances and challenges.
    Goswami TK; Singh M; Dhawan M; Mitra S; Emran TB; Rabaan AA; Mutair AA; Alawi ZA; Alhumaid S; Dhama K
    Hum Vaccin Immunother; 2022 Dec; 18(1):2035117. PubMed ID: 35240914
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulatory T-cell therapy for autoimmune and autoinflammatory diseases: The next frontier.
    Esensten JH; Muller YD; Bluestone JA; Tang Q
    J Allergy Clin Immunol; 2018 Dec; 142(6):1710-1718. PubMed ID: 30367909
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Harnessing the inherent power of chimeric antigen receptor (CAR)-expressing regulatory T cells (CAR-Tregs) to treat autoimmune-related disorders.
    Kahmini FR; Shahgaldi S
    Mol Biol Rep; 2022 May; 49(5):4069-4078. PubMed ID: 35534581
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Foxp3, Regulatory T Cell, and Autoimmune Diseases.
    Tao JH; Cheng M; Tang JP; Liu Q; Pan F; Li XP
    Inflammation; 2017 Feb; 40(1):328-339. PubMed ID: 27882473
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.